or immune responses induced by checkpoint inhibitors Leveraged Finance Fights Melanoma-MRA Established Investigator Award, 2017- 2020 Hidde Ploegh, Children's Hospital Boston Advancing SBI-756, a translation initiation inhibitor, for melanoma therapy: Will further characterize the molecular mechanism of action and therap